← Leaderboards
Isaac O. Donkor
University Of Tennessee Health Sci Ctr
$897,843
Attributed
$897,843
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $292K · FY2005–08$500K$375K$250K$125K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$897,843 · 5
By mechanism
R15$391,655 · 2
R21$249,460 · 1
R03$143,883 · 1
K14$112,845 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Tennessee Health Sci Ctr
Same institution · by research overlap
- Marshall B Elam$1,261,499
- Polly A Hofmann$2,013,232
- Rajendra Raghow$183,920
- Brian M Peters$4,952,404
Others in their field
Top investigators on “Calpain”
- Naren L Banik · Medical University Of South Carolina$13,192,318
- Kenneth D. Tew · Fox Chase Cancer Center$10,798,252
- Melissa Jan Spencer · University Of California Los Angeles$9,310,831
- Edward D Hall · University Of Kentucky$7,363,646
- James W Geddes · University Of Kentucky$7,312,950
- Alexander J Varshavsky · California Institute Of Technology$7,221,759
Research focus
CalpainEnzymesEventCalpain InhibitorInhibitor/AntagonistEndopeptidasesMolecularIn VivoPeptide HydrolasesCellsProtease InhibitorIn VitroAreaDrug Design /Synthesis /ProductionDrug Screening /EvaluationCytotoxicityAchievementDesignEffectivenessCerebral IschemiaCathepsins BAnimals, LaboratoryCell DeathCondition
Grant awards (9)
Water-Soluble and Metabolically Stable Calpain Inhibitors as Cardioprotectants$9,417
R15 · FY2008 · HL · contact PI
Chemoprevention Potential of Calpain Inhibitors$70,883
R03 · FY2007 · CA · contact PI
Water Soluble and Metabolically Stable calpain Inhibitors as Cardioprotectants$21,958
R15 · FY2007 · HL · contact PI
Water-Soluble and Metabolically Stable Calpain Inhibitors as Cardioprotectants$219,000
R15 · FY2006 · HL · contact PI
Chemoprevention Potential of Calpain Inhibitors$73,000
R03 · FY2006 · CA · contact PI
Targeting Calpain for Novel Anticancer Agents$118,980
R21 · FY2005 · CA
Targeting Calpain for Novel Anticancer Agents$130,480
R21 · FY2004 · CA
PROBING THE S'SUBSITES OF CALPAIN$141,280
R15 · FY2002 · HL
DEVELOPING SELECTIVE CALPAIN INHIBITORS$112,845
K14 · FY2000 · HL